BRPI0815110B8 - sistemas de distribuição para solubilização de ingredientes farmaceuticamente ativos insolúveis em água - Google Patents

sistemas de distribuição para solubilização de ingredientes farmaceuticamente ativos insolúveis em água

Info

Publication number
BRPI0815110B8
BRPI0815110B8 BRPI0815110A BRPI0815110A BRPI0815110B8 BR PI0815110 B8 BRPI0815110 B8 BR PI0815110B8 BR PI0815110 A BRPI0815110 A BR PI0815110A BR PI0815110 A BRPI0815110 A BR PI0815110A BR PI0815110 B8 BRPI0815110 B8 BR PI0815110B8
Authority
BR
Brazil
Prior art keywords
pharmaceutically active
active ingredients
insoluble pharmaceutically
delivery systems
water
Prior art date
Application number
BRPI0815110A
Other languages
English (en)
Inventor
Oliani Carlo
Giuliana Tinti Flavia
Cristina Breitkreitz Marcia
Matha Vladimir
Original Assignee
Ems Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ems Sa filed Critical Ems Sa
Publication of BRPI0815110A2 publication Critical patent/BRPI0815110A2/pt
Publication of BRPI0815110A8 publication Critical patent/BRPI0815110A8/pt
Publication of BRPI0815110B1 publication Critical patent/BRPI0815110B1/pt
Publication of BRPI0815110B8 publication Critical patent/BRPI0815110B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

sistemas de distribuição para solubilização de ingredientes farmaceuticamente ativos insolúveis em água. um sistema de distribuição para ingredientes farmaceuticamente ativos insolúveis em água é fornecido. o sistema de distribuição inclui ingrediente(s) farmaceuticamente ativo(s) insolúveis em água, solvente(s) orgânicos(s) e co-solvente(s) anfifílico(s), e uma mistura de tensoativos não iônicos hidrofílicos e hidrofóbicos. por meio da diluição em meio aquoso, esta formulação forma espontaneamente uma dispersão de nanopartículas de tensoativo não iônico.
BRPI0815110A 2007-08-09 2008-08-11 sistemas de distribuição para solubilização de ingredientes farmaceuticamente ativos insolúveis em água BRPI0815110B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0715493A GB2451811A (en) 2007-08-09 2007-08-09 Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
GB0715493.3 2007-08-09
PCT/IB2008/002552 WO2009019604A2 (en) 2007-08-09 2008-08-11 Delivery systems for solubilising water-insoluble pharmaceutical active ingredients

Publications (4)

Publication Number Publication Date
BRPI0815110A2 BRPI0815110A2 (pt) 2015-01-27
BRPI0815110A8 BRPI0815110A8 (pt) 2019-01-29
BRPI0815110B1 BRPI0815110B1 (pt) 2021-03-23
BRPI0815110B8 true BRPI0815110B8 (pt) 2021-05-25

Family

ID=38543271

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0815110A BRPI0815110B8 (pt) 2007-08-09 2008-08-11 sistemas de distribuição para solubilização de ingredientes farmaceuticamente ativos insolúveis em água

Country Status (7)

Country Link
US (1) US9278065B2 (pt)
EP (1) EP2190454B1 (pt)
BR (1) BRPI0815110B8 (pt)
ES (1) ES2663271T3 (pt)
GB (1) GB2451811A (pt)
TR (1) TR201802799T4 (pt)
WO (1) WO2009019604A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2950253B1 (fr) * 2009-09-24 2011-09-23 Ethypharm Sa Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
GB201006038D0 (en) 2010-04-12 2010-05-26 Unilever Plc Improvements relating to antiviral compositions
US20120003162A1 (en) 2010-06-30 2012-01-05 Mcneil-Ppc, Inc. Methods of Preparing Non-Alcohol Bioactive Esential Oil Mouth Rinses
US9084902B2 (en) 2010-06-30 2015-07-21 Mcneil-Ppc, Inc. Non-alchohol bioactive essential oil mouth rinses
SG11201505076UA (en) * 2012-12-31 2015-07-30 Jrx Biotechnology Inc Liquid topical pharmaceutical nano-emulsion formulations
US11260018B2 (en) 2015-09-17 2022-03-01 Jrx Biotechnology, Inc. Approaches for improving skin hydration and moisturization
WO2021257913A1 (en) * 2020-06-20 2021-12-23 Chavan Neha Compositions for solubilizing water-insoluble active ingredients
CN119343155A (zh) * 2022-04-15 2025-01-21 马克·迈克尔·门宁格 水溶性差的化合物的乳液制剂

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE445174B (sv) 1978-03-07 1986-06-09 Sandoz Ag Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
GB8903804D0 (en) 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
US5756450A (en) 1987-09-15 1998-05-26 Novartis Corporation Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
DE68900991D1 (de) 1988-01-29 1992-04-23 Sankyo Co Cyclosporin-zusammensetzungen.
HU201567B (en) 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
KR0148748B1 (ko) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US5342625A (en) 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
US20020107183A1 (en) 1993-04-20 2002-08-08 Monika Petszulat Pharmaceutical preparations comprising cyclosporin for oral administration
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
DE4418155A1 (de) 1993-06-01 1994-12-08 Basf Ag Verfahren zur Herstellung von N,N-disubstituierten 3-Aminoacrylsäureestern
JPH10504291A (ja) 1994-07-22 1998-04-28 ジー．ディー．サール アンド カンパニー 自己乳化性ドラッグデリバリーシステム
KR0167613B1 (ko) * 1994-12-28 1999-01-15 한스 루돌프 하우스, 니콜 케르커 사이클로스포린-함유 연질캅셀제 조성물
KR970064620A (ko) * 1996-03-05 1997-10-13 임성기 사이클로스포린-함유 외용약제 조성물
GB9721367D0 (en) * 1997-10-09 1997-12-10 Univ Liverpool Delivery system
WO2000003753A2 (en) 1998-07-14 2000-01-27 Em Industries, Inc. Microdisperse drug delivery systems
DE69924004T2 (de) 1998-12-22 2006-02-09 United States Of America Represented By The Secretary, Department Of Health & Human Services Verabreichungssystem für wasserunlösliche arzneistoffe
DK1154759T3 (da) * 1998-12-30 2008-12-08 Dexcel Ltd Dispergerbart koncentrat til indgift af cyclosporin
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6623765B1 (en) 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
GB0029843D0 (en) 2000-12-07 2001-01-24 Univ Belfast Drug delivery system
KR100441167B1 (ko) * 2001-12-27 2004-07-21 씨제이 주식회사 마이크로에멀젼 예비 농축액 조성물
US20040033959A1 (en) * 2002-07-19 2004-02-19 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical compositions for hepatitis C viral protease inhibitors
KR20040015624A (ko) * 2002-08-13 2004-02-19 대한뉴팜(주) 플로르페니콜을 활성성분으로 함유하는 경구투여용약제학적 조성물
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
UA81028C2 (en) * 2003-04-02 2007-11-26 Boehringer Ingelheim Int Pharmaceutical compositions for hepatitis c viral protease inhibitors
US20060094692A1 (en) * 2004-10-28 2006-05-04 Bionumerik Pharmaceuticals, Inc. Pharmaceutical formulations of camptothecins and process for making same
US20090062397A1 (en) * 2007-04-27 2009-03-05 Schering-Plough Animal Health Corporation Compounds and methods for enhancing solubility of florfenicol and structurally-related antibiotics using cyclodextrins

Also Published As

Publication number Publication date
WO2009019604A2 (en) 2009-02-12
ES2663271T3 (es) 2018-04-11
TR201802799T4 (tr) 2018-03-21
GB2451811A (en) 2009-02-18
EP2190454A2 (en) 2010-06-02
BRPI0815110B1 (pt) 2021-03-23
WO2009019604A3 (en) 2009-07-23
US9278065B2 (en) 2016-03-08
BRPI0815110A2 (pt) 2015-01-27
US20120177692A1 (en) 2012-07-12
BRPI0815110A8 (pt) 2019-01-29
GB0715493D0 (en) 2007-09-19
EP2190454B1 (en) 2017-12-20

Similar Documents

Publication Publication Date Title
BRPI0815110A8 (pt) sistemas de distribuição para solubilização de ingredientes farmaceuticamente ativos insolúveis em água
AR073801A1 (es) Emulsiones de liberacion modificadas para aplicacion en la piel o mucosa vaginal
CY1121496T1 (el) Μια μεθοδος για τη διαμορφωση του ρυθμου απελευθερωσης των μικροενθυλακωμενων δραστικων συστατικων
BRPI0717509A2 (pt) sistema de liberação controlada para aplicação nasal de neurotransmissores
ECSP088668A (es) Sistema de administracion de plaguicidas
AR065032A1 (es) Emulsion dermatologica y procedimiento de preparacion
CL2009001080A1 (es) Procedimiento para encapsular agentes biologicamente activos en un vehiculo en forma de particulas, que comprende solubilizar en un agente de apareamiento de ion hidrofobo y un disolvente, disolver, formar la emulsion y obtener el vehiculo; vehiculo en forma de particulas; y composicion farmaceutica que comprende el vehiculo.
AR113031A1 (es) Composiciones de nanopartículas lipídicas (lnp) que comprende arn
CL2007000813A1 (es) Metodos para preparar agregados de micelas de proteina de suero y un agente activo; agregados; producto alimenticio o producto cosmetico; y uso de las micelas de proteina de suero.
WO2006129161A3 (en) Vitamin formulation
BRPI0714399B8 (pt) composição farmacêutica líquida oral
AR059843A1 (es) Nuevas composiciones topicas en forma de emulsion ac/ag que comprenden un glicol propenetrante
BR112014027039A2 (pt) formulação farmacêutica tópica não aquosa; uso de formulação farmacêutica não aquosa; formulação não aquosa; e método
CL2009002073A1 (es) Composicion farmaceutica solida para la liberacion controlada de un agente activo activo en el tracto gastrointestinal que comprende al menos un agente acido con solubilidad de menos de 0,3 mg/ml en solucion acuosa a un ph alrededor del pka del agente acido, un polimero hidrofilo, un alcanizador; uso en trastornos cardiovasculares.
BR112012010026A2 (pt) dispositivo oculares de entrega de drogas
TR200801336T1 (tr) Kararlılığı artmış zayıf su çöznurluğune sahip ilaçların preparasyonuna yönelik kompozisyonlar ve yöntemler.
AR053819A1 (es) Productos de microcapsiula de liberacion rapida
ES2530774T3 (es) Método para producir partículas secas
BR112015014523A2 (pt) nanossuspensão estabilizada, composição farmacêutica, e, método de tratamento de um paciente
AR059350A1 (es) Formulacion farmaceutica para aerosoles con dos o mas principios activos y al menos una sustancia tensioactiva
BRPI0821616B8 (pt) composição micelar de copolímero de bloco anfifílico contendo taxano e método para preparação da mesma
ECSP10010184A (es) Producto de dispersión sólida que contiene un compuesto a base de n-aril-urea
WO2017037593A3 (zh) 用于减少局部脂肪的医药组成物及其用途
AR058921A1 (es) Mezcla de disolventes para preparar una formulacion de concentrado de liquido hidrosoluble de compuestos plaguicidas organicos
AR056808A1 (es) Formulacion de aceite en agua de avermectinas

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B04C Request for examination: application reinstated [chapter 4.3 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/03/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/08/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF